✦ LIBER ✦

Pre-clinical evaluation of the activity of gemcitabine as a basis for regional chemotherapy of pancreatic and colorectal cancer

✍ Scribed by M Kornmann; U Butzer; J Blatter; HG Beger; KH Link

Book ID: 117817600
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 95 KB
Volume: 26
Category: Article
ISSN: 0748-7983
DOI: 10.1053/ejso.2000.0951

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CEA as an indicator for the efficacy of

CEA as an indicator for the efficacy of regional chemotherapy for liver metastases of colorectal cancer

✍ A. Quentmeier; P. Hohenberger; H. Feil; P. Schlag 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 118 KB

A Phase I Clinical Trial of Ascorbic Aci

A Phase I Clinical Trial of Ascorbic Acid and Gemcitabine for the Treatment of Metastatic Pancreatic Cancer

✍ Jessemae Welsh; Brett Wagner; Pamela Zehr; Daniel Berg; Thorvardur Halfdanarson; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Phase II Clinical Trial to Evaluate the

Phase II Clinical Trial to Evaluate the Efficacy and Safety of Activated T-Lymphocyte Cell Therapy in Gemcitabine Refractory Advanced Pancreatic Cancer

✍ Chung, Moon Jae ;Park, Jeong Youp ;Bang, Seungmin ;Park, Seung Woo ;Chung, Jae B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Phase II clinical trial to evaluate the

Phase II clinical trial to evaluate the efficacy and safety of activated T-lymphocyte cell therapy in gemcitabine refractory advanced pancreatic cancer

✍ Chung, Moon Jae; Park, Jeong Youp; Bang, Seungmin; Park, Seung Woo; Chung, Jae B 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 165 KB

547 Improvements in survival and clinica

547 Improvements in survival and clinical benefit with the use of gemcitabine (GEM) as first-line therapy for advanced pancreatic cancer: A randomized trial

✍ M. Moore 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Clinical evaluation of serum tumor-assoc

Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patients

✍ Fiorella Guadagni; Mario Roselli; Teresa Amato; Maurizio Cosimelli; Ernesto Mann 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB

A novel tumor marker, tumor-associated glycoprotein-72 (TAG-72), has been identified using monoclonal antibody (MAb) B72.3. Using immunohistochemical techniques, TAG-72 has been found in carcinomas of various origin including colon, stomach, breast, lung, prostate, and ovary, as well as in body flui